Durata Therapeutics Inc (DRTX.OQ)
DRTX.OQ on NASDAQ Stock Exchange Global Market
9.23USD
10:56am EDT
9.23USD
10:56am EDT
Price Change (% chg)
$0.57 (+6.58%)
$0.57 (+6.58%)
Prev Close
$8.66
$8.66
Open
$8.75
$8.75
Day's High
$9.23
$9.23
Day's Low
$8.75
$8.75
Volume
10,614
10,614
Avg. Vol
26,907
26,907
52-wk High
$10.50
$10.50
52-wk Low
$6.65
$6.65
About
Durata Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $230.59 |
| Shares Outstanding (Mil.): | 26.63 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DRTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -4.36 | -- | -- |
| ROI: | -121.68 | -2.58 | 18.76 |
| ROE: | -292.12 | -2.66 | 19.59 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

